Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome

J Med Genet. 2003 Jan;40(1):74-8. doi: 10.1136/jmg.40.1.74.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / blood
  • Abnormalities, Multiple / drug therapy*
  • Abnormalities, Multiple / genetics*
  • Acebutolol / administration & dosage
  • Acebutolol / therapeutic use
  • Adolescent
  • Adrenergic beta-1 Receptor Antagonists*
  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / therapeutic use*
  • Child
  • Child, Preschool
  • Chronobiology Disorders / blood
  • Chronobiology Disorders / drug therapy*
  • Circadian Rhythm / drug effects
  • Circadian Rhythm / physiology
  • Cohort Studies
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Melatonin / administration & dosage
  • Melatonin / blood
  • Melatonin / therapeutic use*
  • Receptors, Adrenergic, beta-1 / physiology
  • Sleep / drug effects*
  • Sleep / physiology*
  • Syndrome

Substances

  • Adrenergic beta-1 Receptor Antagonists
  • Adrenergic beta-Antagonists
  • Receptors, Adrenergic, beta-1
  • Acebutolol
  • Melatonin